Powered by 
Translate
Translate
BioQuest, Corp. (BQST) Upgraded from Shell Status on OTC Markets, Prepares for Acquisition of BotMakers, Inc.
Newport Beach, CA September 12, 2024 – BioQuest, Corp. (OTC: BQST), a publicly traded company, is pleased to announce that its status on OTC Markets has been upgraded from Shell Status, reflecting its operational progress and ongoing efforts to acquire BotMakers, Inc., a leader in AI-powered conversational voice and chat solutions. This upgrade marks a pivotal step as BioQuest transforms into an active, operational company poised for growth.
BioQuest's acquisition of BotMakers, Inc. is key to its strategic plan. BotMakers, based in Katy, Texas, specializes in AI-driven communication technology, offering solutions that automate inbound and outbound interactions across industries. Its flagship product, AI Callers, streamlines customer engagement, reduces costs, and enhances user experiences with tailored AI solutions.
BioQuest’s Commitment to Future Growth
With its upgraded OTC status and acquisition of BotMakers in process, BioQuest is committed to becoming a fully reporting company. This will provide greater transparency and accountability for investors, positioning the company for future growth. BioQuest also plans to uplist to a major exchange, such as NASDAQ, in the future, supporting its long-term strategy of enhancing operations and product offerings.
"Our upgrade from Shell Status reflects the progress we've made in advancing our operations and preparing for the BotMakers acquisition," said CEO of BioQuest, Inc. "This is a key milestone in BioQuest's transformation, and we look forward to leveraging BotMakers’ innovative AI solutions to drive our growth."
About BotMakers, Inc.
BotMakers, Inc. is a technology company specializing in AI-powered conversational voice and chat solutions. Its AI-driven products help organizations automate communication, improve customer engagement, and reduce operational costs. BotMakers serves clients across multiple sectors, including finance, nonprofits, and technology, with its flagship product AI Callers leading its suite of offerings.
About BioQuest, Corp.
BioQuest, Inc. (OTC: BQST) is a publicly traded company focused on innovative technologies, particularly in AI and automation. Currently in the process of acquiring BotMakers, Inc., BioQuest is transitioning into a fully operational and reporting entity with plans for a future uplisting to a major exchange .
For more information about BioQuest, Inc., visit www.bioquestcorp.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws, including but not limited to statements concerning BioQuest, Inc.'s acquisition of BotMakers, Inc., the anticipated benefits of the acquisition, future operational plans, plans for growth, future financial performance, and expectations regarding uplisting to a major exchange. These statements are based on current expectations and projections about future events and are subject to various risks and uncertainties, including the possibility that the acquisition may not occur or may be delayed, the expected benefits of the acquisition may not be realized, BioQuest’s ability to successfully uplist to a major exchange, market conditions, and other risks.
Actual results could differ materially from those described in the forward-looking statements. BioQuest undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Safe Harbor Statement:
This release includes forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. BioQuest, Inc. assumes no obligation to update any forward-looking information contained in this press release.
